Dr Suzanne M Furesz, MD | |
1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110-1003 | |
(314) 362-1700 | |
(314) 362-9878 |
Full Name | Dr Suzanne M Furesz |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 1 Barnes Jewish Hospital Plz, Saint Louis, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093851909 | NPI | - | NPPES |
205503402 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 108408 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Barnes Jewish Hospital | Saint louis, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Washington University | 9830008770 | 2506 |
News Archive
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
CrystalGenomics, Inc., a leading biopharmaceutical company developing novel small molecule therapeutics announced today that it will merge with BexPharm, a specialty pharmaceutical company that imports and distributes foreign market approved drugs in Korea.
Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.
Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology for Clinicians Symposium organized by the European Society for Medical Oncology (ESMO) in Nice this week.
› Verified 9 days ago
Entity Name | Washington University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
CrystalGenomics, Inc., a leading biopharmaceutical company developing novel small molecule therapeutics announced today that it will merge with BexPharm, a specialty pharmaceutical company that imports and distributes foreign market approved drugs in Korea.
Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.
Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology for Clinicians Symposium organized by the European Society for Medical Oncology (ESMO) in Nice this week.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Suzanne M Furesz, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-1700 | Dr Suzanne M Furesz, MD 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110-1003 Ph: (314) 362-1700 |
News Archive
Ruthigen Inc., a biopharmaceutical company focused on pioneering new therapies to improve patient outcomes and reduce healthcare costs associated with infections related to post-operative invasive procedures, announces the initiation of a Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery.
CrystalGenomics, Inc., a leading biopharmaceutical company developing novel small molecule therapeutics announced today that it will merge with BexPharm, a specialty pharmaceutical company that imports and distributes foreign market approved drugs in Korea.
Longevity Biotech, Inc. has received an award from the National Multiple Sclerosis Society through Fast Forward, the Society's commercial research funding program, to evaluate LBT-3627 in preclinical models as a potential disease-modifying therapeutic agent.
Millions of cancer patients worldwide may soon be able to receive more effective, personalized treatments for their disease thanks to developments in the understanding of cancer biology, experts will say at the Cancer Biology for Clinicians Symposium organized by the European Society for Medical Oncology (ESMO) in Nice this week.
› Verified 9 days ago
Dr. Robert Shi-heng Young, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Sumera Younus, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd Ste 387c, Saint Louis, MO 63131 Phone: 314-996-5900 | |
Dr. James Matthew Freer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Rachel Hannah Bardowell, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Jabon L Ellis, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-257-8222 Fax: 915-742-2653 | |
Dr. Patrick Hodge White, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Jeffrey B Friesen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 |